Stockscreener 앱 받기
9.98
2.15%
0.21
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
While Shareholders of Niagen Bioscience (NASDAQ:NAGE) Are in the Black Over 3 Years, Those Who Bought a Week Ago Aren't so Fortunate - 富途牛牛
Q3 EPS Forecast for Niagen Bioscience Decreased by Analyst - MarketBeat
Niagen Bioscience (NASDAQ:NAGE) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Niagen Bioscience's Q2 2025 Earnings: A Catalyst for NAD+ Market Leadership and Long-Term Value Creation - AInvest
Niagen Bioscience, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) - Seeking Alpha
Quant Models Detect Momentum Reversal in Niagen Bioscience Inc.Stock Surge & Daily Oversold Stock Bounce Ideas - 선데이타임즈
Q2 EPS Estimate for Niagen Bioscience Boosted by Analyst - MarketBeat
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Is Niagen Bioscience Inc. forming a bullish divergenceWeekly Profit Recap & Proven Capital Preservation Tips - mustnews.co.kr
Is Niagen Bioscience Inc. a defensive stockJuly 2025 Big Picture & Momentum Based Trading Signals - thegnnews.com
RSI Divergence May Trigger a Bounce in Niagen Bioscience Inc.New Guidance & Verified Chart Pattern Signals - newsimpact.co.kr
Is Niagen Bioscience Inc. forming higher highs and higher lowsMarket Activity Summary & AI Powered Market Trend Analysis - thegnnews.com
Bullish Candlestick Pattern Forms in Niagen Bioscience Inc.2025 Year in Review & Free Fast Gain Swing Trade Alerts - metal.it
HC Wainwright Issues Positive Forecast for Niagen Bioscience (NASDAQ:NAGE) Stock Price - MarketBeat
Niagen Bioscience Inc. Stock Approaches Key Moving Average2025 Earnings Surprises & AI Powered Buy/Sell Recommendations - 선데이타임즈
Q2 EPS Estimate for Niagen Bioscience Increased by Analyst - MarketBeat
Niagen: Imminent Trigger For A Significant Move Up (Technical Analysis) - Seeking Alpha
Quince, Niagen, Intrabio busy in rare A-T disease - BioWorld MedTech
Promising Growth and Innovation Drive Buy Rating for Niagen Bioscience - TipRanks
Equities Analysts Offer Predictions for NAGE Q3 Earnings - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Average PT from Brokerages - MarketBeat
Momentum Screeners Rank Niagen Bioscience Inc. in Top 5 TodayConsistent Income Focused Trade List Analyzed - beatles.ru
Niagen Bioscience stock price target raised to $12 from $11 at H.C. Wainwright - Investing.com Canada
Real time scanner hits for Niagen Bioscience Inc. explainedRisk Balanced Picks for Safer Trading - Newser
Niagen Bioscience Reports Strong Q2 Growth and Outlook - TipRanks
News impact scoring models applied to Niagen Bioscience Inc.In-Depth Stock Trading Volume Analysis - Newser
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Earnings Beat - MarketBeat
Risk adjusted return profile for Niagen Bioscience Inc. analyzedSafe and Scalable Return Strategy Blueprint - Newser
Can Niagen Bioscience Inc. rally from current levelsLow Risk Strategy with Smart Entry Zones - Newser
Roth Capital Cuts Earnings Estimates for Niagen Bioscience - Defense World
Will a bounce in Niagen Bioscience Inc. offer an exitProven Trading System with Consistent Gains - Newser
Niagen Bioscience, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of “Buy” by Brokerages - Defense World
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Should you wait for a breakout in Niagen Bioscience Inc.Free Fundamental Growth Stock Analysis - Newser
Niagen Bioscience Reports Strong Q2 Sales Growth - The Globe and Mail
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates - MSN
Niagen Bioscience: Q2 Earnings Snapshot - New Haven Register
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Niagen Bioscience shares rise 21.91% premarket after Q2 sales beat estimates. - AInvest
Earnings call transcript: Niagen Bioscience Q2 2025 earnings beat expectations - Investing.com
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - BioSpace
Niagen NAGE Q2 2025 Earnings Call Transcript - Mitrade
Niagen Bioscience shares rise 24.88% after-hours after Q2 sales beat estimates. - AInvest
Transcript : Niagen Bioscience, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
0.94%
1.72%
자본화:
|
볼륨(24시간):